IL-6 increases primed cell expansion and survival

被引:114
作者
Rochman, I
Paul, WE
Ben-Sasson, SZ
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumro Immunol, Jerusalem, Israel
关键词
D O I
10.4049/jimmunol.174.8.4761
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Cytochrome c-specific CD4 T cells from transgenic donors transferred to syngeneic B10.A mice expand more vigorously upon immunization if exogenous IL-6 is provided during the initial phase of immunization. The resultant increase in the frequency and number of Ag-specific cells is observed in the blood, lymph nodes, spleen, liver, and lung and persists for at least 3 mo. Treatment of immunized recipients with anti-IL-6 or use of IL-6 knockout recipients reduced the frequency of Ag-specific CD4 T cells during a comparable period, indicating that IL-6 is physiologically involved in the expansion of memory and/or effector cells and thus in the persistence of memory. IL-6 did not alter the duration of Ag-presenting activity. Both USE dilution studies and labeling with BrdU indicated that IL-6 does not effect proliferative rates of responding CD4 T cells. By contrast, annexin V staining was diminished in responding cells from the IL-6-treated animals, particularly among those cells that had undergone five or more divisions. These results indicate that IL-6 reduces the level of apoptosis among Ag-stimulated cells; thus, it plays a central role in determining numbers of memory and/or effector CD4 T cells in response to immunization over extended periods.
引用
收藏
页码:4761 / 4767
页数:7
相关论文
共 65 条
[1]
Adkins B, 1996, J IMMUNOL, V157, P1343
[2]
Interleukin 6 is required for the development of collagen-induced arthritis [J].
Alonzi, T ;
Fattori, E ;
Lazzaro, D ;
Costa, P ;
Probert, L ;
Kollias, G ;
De Benedetti, F ;
Poli, V ;
Ciliberto, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) :461-468
[3]
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo [J].
Atreya, R ;
Mudter, J ;
Finotto, S ;
Müllberg, J ;
Jostock, T ;
Wirtz, S ;
Schütz, M ;
Bartsch, B ;
Holtmann, M ;
Becker, C ;
Strand, D ;
Czaja, J ;
Schlaak, JF ;
Lehr, HA ;
Autschbach, F ;
Schürmann, G ;
Nishimoto, N ;
Yoshizaki, K ;
Ito, H ;
Kishimoto, T ;
Galle, PR ;
Rose-John, S ;
Neurath, MF .
NATURE MEDICINE, 2000, 6 (05) :583-588
[4]
Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death [J].
Ayroldi, E ;
Zollo, O ;
Cannarile, L ;
D' Adamio, FD ;
Grohmann, U ;
Delfino, DV ;
Riccardi, C .
BLOOD, 1998, 92 (11) :4212-4219
[5]
CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes:: Involvement of NF-κB, AP-1, and C/EBP [J].
Baccam, M ;
Woo, SY ;
Vinson, C ;
Bishop, GA .
JOURNAL OF IMMUNOLOGY, 2003, 170 (06) :3099-3108
[6]
Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells [J].
Bartz, H ;
Büning-Pfaue, F ;
Türkel, Ö ;
Schauer, U .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 129 (03) :438-445
[7]
Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells [J].
Bauer, M ;
Redecke, V ;
Ellwart, JW ;
Scherer, B ;
Kremer, JP ;
Wagner, H ;
Lipford, GB .
JOURNAL OF IMMUNOLOGY, 2001, 166 (08) :5000-5007
[8]
Beckett S, 2002, CALL CENT MAG, V15, P8
[9]
Ben-Sasson SZ, 2000, EUR J IMMUNOL, V30, P1308, DOI 10.1002/(SICI)1521-4141(200005)30:5<1308::AID-IMMU1308>3.0.CO
[10]
2-I